Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study

✍ Scribed by Liu, Joyce F; Barry, William T; Birrer, Michael; Lee, Jung-Min; Buckanovich, Ronald J; Fleming, Gini F; Rimel, BJ; Buss, Mary K; Nattam, Sreenivasa; Hurteau, Jean; Luo, Weixiu; Quy, Philippa; Whalen, Christin; Obermayer, Lisa; Lee, Hang; Winer, Eric P; Kohn, Elise C; Ivy, S Percy; Matulonis, Ursula A

• Book ID: 126924873
• Publisher: The Lancet
• Year: 2014
• Tongue: English
• Weight: 300 KB
• Volume: 15
• Category: Article
• ISSN: 1470-2045
• DOI: 10.1016/s1470-2045(14)70391-2